Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05463341 · ClinicalTrials.gov registry record · NA
Evaluating an Intervention to Prevent Overdoses in Rural and Urban Counties
A NA study of Harm Reduction and Opiate Overdose, sponsored by Nationwide Children's Hospital.
- Active
- Registry status
- NA
- Development phase
- 2,400
- Enrollment target
- 1
- Study location
NCT05463341: Active NA study of Harm Reduction and Opiate Overdose, sponsored by Nationwide Children's Hospital.
NCT05463341 is a NA study of Harm Reduction and Opiate Overdose that is active but no longer recruiting, run by Nationwide Children's Hospital. The registered enrollment target is 2,400 participants, above the 737-participant average among 7 other Harm Reduction trials with a reported enrollment target (226% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05463341, a NA study of Harm Reduction and Opiate Overdose, is active but no longer recruiting, sponsored by Nationwide Children's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 2,400 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to investigate the feasibility, acceptability, and associated benefits and harms of integrating FTS education and distribution into select Project DAWN sites in rural and urban communities in Ohio.
Primary Outcome
Key informant interviews with all site personnel and peer recovery mentors. Quantitative Data/Process Measures: * \# interested Project DAWN sites * \# Project DAWN sites enrolled * \# potential participants who request to enroll * \# participants successfully enrolled * \# people who receive FTS education and testing materials at baseline * \# replacement FTS requested/distributed * total # FTS distributed * proportion of participants in the intervention arm who complete the biweekly surveys
Conditions Studied
Interventions
- BEHAVIORAL Fentanyl Test Strips
Study Locations (1)
Ohio
- Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,400 participants |
| Start Date | 2022-09-09 |
| Est. Completion | 2026-01-31 |
| Phase | NA |
What the registry record for NCT05463341 still lists
NCT05463341 is an interventional study that assigns participants to a tested intervention. Its 2,400 participants enrollment target places it among the larger protocols in the corpus, above the 737-participant average among 7 other Harm Reduction trials with a reported enrollment target (226% higher).
The record links to 3 conditions, with Harm Reduction appearing as the primary indexed condition, and to 1 intervention - of which Fentanyl Test Strips is the first listed.
NCT05463341 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05463341 about?
NCT05463341 is a clinical study titled "Evaluating an Intervention to Prevent Overdoses in Rural and Urban Counties". The purpose of the study is to investigate the feasibility, acceptability, and associated benefits and harms of integrating FTS education and distribution into select Project DAWN sites in rural and urban communities in Ohio.
What is the current status of trial NCT05463341?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 2,400 participants. The study started on 2022-09-09. Estimated completion is 2026-01-31.
What conditions does trial NCT05463341 study?
This clinical trial studies the following conditions: Harm Reduction, Opiate Overdose, Fentanyl Overdose.
What interventions are being tested in trial NCT05463341?
The interventions under investigation include: Fentanyl Test Strips (BEHAVIORAL).
Who is sponsoring clinical trial NCT05463341?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05463341 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Harm Reduction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Teaching Health Resilience in a Hospital Setting: A Peer-led Intervention
RECRUITING · NA
-
A Randomized Clinical Trial of a Novel Drug Education and Diversion Program (iDECIDE) for Middle and High School Students
RECRUITING · NA
-
Noncombustible Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers
RECRUITING · NA
-
Electronic Harm Reduction Treatment for Alcohol
RECRUITING · Phase 3
-
Shelter HArm Reduction Evaluation
RECRUITING
-
Vending Machine Naloxone Distribution for Your Community (VENDY)
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05185440 · 2,400 participants · NA
Reducing Alcohol Involved Sexual Violence in Higher Education
- NCT05285527 · 2,400 participants · NA
MiSight 1 Day Safety Post-Approval Study
- NCT05738330 · 2,400 participants · NA
Symptom Monitoring in Hemodialysis
- NCT05833360 · 2,400 participants
Prospective Study of oncRNA Stratification of Cancer by Size and Stage
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI